• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Apr 30, 2018
Company News

Allergan drops RORgammaT inhibitor for psoriasis

BioCentury | Jan 11, 2017
Clinical News

Allergan discloses Phase II miss in LXR program

BioCentury | Sep 19, 2016
Company News

Vitae, Allergan deal

BioCentury | Sep 14, 2016
Top Story

Allergan acquiring Vitae

BioCentury | May 30, 2016
Strategy

Taking Takeda global

How Takeda CEO Weber plans to claim top-tier positions in GI, cancer, CNS
BioCentury | Apr 4, 2016
Finance

1Q approvals

BioCentury | Apr 4, 2016
Finance

Fundamental reset

How biotech companies, bankers and buysiders will adjust to a new base in 2Q16
BioCentury | Mar 25, 2016
Financial News

Vitae raises $35M in follow-on

BioCentury | Mar 21, 2016
Clinical News

VTP-43742: Phase IIa data

BioCentury | Mar 21, 2016
Analyst Picks & Changes

Analyst picks & changes

Items per page:
1 - 10 of 16